ReviewDer Nervenarzt2009
[Comorbidity of substance use disorders and attention-deficit hyperactivity disorders: pathogenesis and therapy].
Review in Der Nervenarzt, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 8 citations in OpenAlex.
- [Methylphenidate. Therapy option for adults with ADHD and comorbid substance use disorder?].Der Nervenarzt · 2010Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Substance use disorders (e.g. substance addiction, substance abuse) and adult attention-deficit hyperactivity disorders (adult ADHD) are frequent psychiatric disorders with a high individual and social relevance. Complex interactions of common and divergent susceptibility genes and environmental factors are important for both disorders which have a relatively high heritability. Substance use disorders and adult ADHD are both associated with an increased risk for additional axis I disorders. The results of studies with respect to the comorbidity of adult ADHD and substance use disorders are inconsistent. Different hypotheses with respect to comorbidity are under discussion. A standardised diagnostic procedure has to be followed. The consequence of misdiagnosing adult ADHD with comorbid substance use disorder is that relevant specific therapeutic procedures will not be followed or stimulants will be prescribed too easily for individuals with substance use disorders. Multimodal integrated therapeutic concepts for the comorbidity of substance use disorders and adult ADHD have yet to be developed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.